The stock price of enGene Holdings Inc (NASDAQ: ENGN) has dropped by -5.26 compared to previous close of 9.50. businesswire.com reported 2024-06-14 that BOSTON & MONTREAL–(BUSINESS WIRE)–enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage genetic medicines company whose non-viral, intravesical lead product candidate, EG-70, is in a pivotal study for BCG-unresponsive high-risk non-muscle invasive bladder cancer (NMIBC), today announced its financial results for the second quarter ended April 30, 2024, and provided a business update. “Our $200 million private placement in February positioned us well to execute our p.
Is It Worth Investing in enGene Holdings Inc (NASDAQ: ENGN) Right Now?
Moreover, the 36-month beta value for ENGN is -0.63. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ENGN is 16.13M and currently, short sellers hold a 1.06% of that float. On August 01, 2024, ENGN’s average trading volume was 127.71K shares.
ENGN’s Market Performance
The stock of enGene Holdings Inc (ENGN) has seen a 0.00% decrease in the past week, with a 0.11% rise in the past month, and a -43.36% fall in the past quarter. The volatility ratio for the week is 15.33%, and the volatility levels for the past 30 days are at 11.84% for ENGN. The simple moving average for the past 20 days is 0.06% for ENGN’s stock, with a -22.07% simple moving average for the past 200 days.
Analysts’ Opinion of ENGN
Many brokerage firms have already submitted their reports for ENGN stocks, with Wells Fargo repeating the rating for ENGN by listing it as a “Overweight.” The predicted price for ENGN in the upcoming period, according to Wells Fargo is $30 based on the research report published on April 22, 2024 of the current year 2024.
Guggenheim, on the other hand, stated in their research note that they expect to see ENGN reach a price target of $34. The rating they have provided for ENGN stocks is “Buy” according to the report published on April 15th, 2024.
UBS gave a rating of “Buy” to ENGN, setting the target price at $37 in the report published on March 28th of the current year.
ENGN Trading at -4.38% from the 50-Day Moving Average
After a stumble in the market that brought ENGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.92% of loss for the given period.
Volatility was left at 11.84%, however, over the last 30 days, the volatility rate increased by 15.33%, as shares surge +2.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.99% lower at present.
During the last 5 trading sessions, ENGN rose by +2.78%, in comparison to the 20-day moving average, which settled at $9.01. In addition, enGene Holdings Inc saw -2.49% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ENGN starting from FONDS DE SOLIDARITE DES TRAVAI, who sale 47,854 shares at the price of $15.00 back on Apr 22 ’24. After this action, FONDS DE SOLIDARITE DES TRAVAI now owns 3,036,153 shares of enGene Holdings Inc, valued at $717,810 using the latest closing price.
FONDS DE SOLIDARITE DES TRAVAI, the 10% Owner of enGene Holdings Inc, sale 100 shares at $15.00 during a trade that took place back on Apr 19 ’24, which means that FONDS DE SOLIDARITE DES TRAVAI is holding 3,084,007 shares at $1,500 based on the most recent closing price.
Stock Fundamentals for ENGN
The total capital return value is set at -0.17. Equity return is now at value -103.02, with -94.04 for asset returns.
Based on enGene Holdings Inc (ENGN), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -1.44. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -11.5.
Currently, EBITDA for the company is -25.89 million with net debt to EBITDA at 2.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 42.80.
Conclusion
To wrap up, the performance of enGene Holdings Inc (ENGN) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
